Aptamer Group First Half 2023 Earnings: UK£0.038 loss per share (vs UK£0.018 loss in 1H 2022)

Simply Wall St

March 17, 2023

Aptamer Group (LON:APTA) First Half 2023 Results

Key Financial Results

Revenue: UK£1.02m (down 26% from 1H 2022).
Net loss: UK£2.63m (loss widened by 139% from 1H 2022).
UK£0.038 loss per share (further deteriorated from UK£0.018 loss in 1H 2022).

earnings-and-revenue-history — AIM:APTA Earnings and Revenue History March 17th 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

Aptamer Group Earnings Insights

Looking ahead, revenue is forecast to grow 61% p.a. on average during the next 2 years, compared to a 14% growth forecast for the Biotechs industry in the United Kingdom.

Performance of the British Biotechs industry.

The company's shares are down 23% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 5 warning signs for Aptamer Group (of which 3 make us uncomfortable!) you should know about.

If you're looking to trade Aptamer Group, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.